AIDS: Nicotinic Immune Modulation in HIV-1 Infection

Deadline
Jan 17, 2017
OPPORTUNITY NO.
RFA-DA-17-020
MECHANISM
R01
RESEARCH AREA(S)
SYNOPSIS

Nicotinic Immune Modulation in the Presence of HIV-1 Infection

The FOA encourages the submission of research project applications to determine nicotine’s modulatory effects on peripheral and central immune system functions in the presence of HIV-1 infection.  Specifically, NIDA is particularly interested in projects exploring the ability of nicotine to produce anti-inflammatory and protective effects, and the translational potential of the new knowledge in attenuating HIV-induced pathologies and HIV-associated CNS complications such as neurological/cognitive disorders.  

Deadlines:

  • Pre-Application Submission: Dec. 17, 2017
  • Application Submission: 5:00 PM local time of applicant organization, Jan. 17, 2017
ELIGIBILITY

Any individual(s) with the skills, knowledge, and resources necessary to carry out the proposed research as the Program Director(s)/Principal Investigator(s) (PD(s)/PI(s)) is invited to work with his/her organization to develop an application for support. Individuals from underrepresented racial and ethnic groups as well as individuals with disabilities are always encouraged to apply for NIH support.